Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Bellicum Pharmaceuticals Inc. buy marge

Bellicum Pharmaceuticals Inc.
Start price
€120.87
17.04.17 / 50%
Target price
€162.36
13.12.19
Performance (%)
-93.05%
End price
€8.40
13.12.19
Summary
This prediction ended on 13.12.19 with a price of €8.40. The BUY prediction by marge for Bellicum Pharmaceuticals Inc. performed very badly with a performance of -93.05%. marge has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Bellicum Pharmaceuticals Inc. - - - -
iShares Core DAX® 1,43 % 1,58 % 13,25 % 61,14 %
iShares Nasdaq 100 1,89 % -2,28 % 2,99 % 88,34 %
iShares Nikkei 225® -1,62 % 7,95 % 27,69 % 65,18 %
iShares S&P 500 1,92 % -0,28 % 2,99 % 61,15 %

Comments by marge for this prediction

In the thread Bellicum Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -93.05%
Target price 16.236
Change
Ends at 13.12.19

marge stimmt der Buy-Einschätzung von datca zu

marge stimmt am 17.04.2017 der Buy-Einschätzung von datca mit dem Kursziel 18$ zu.
Überschrift: BLCM mit beeindruckenden Daten bei Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia

marge 
0
Report Share
17.04.17
Prediction Buy
Perf. (%) -93.05%
Target price 16.236
Change
Ends at 13.12.19

Buy beendet

marge 
0
Report Share
13.12.19

Stopped prediction by marge for Bellicum Pharmaceuticals Inc.

buy
Bellicum Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.40
13.12.19
€7.00
04.11.21
-79.17%
05.11.21

marge 
13.12.19 50%